Domov › Nadváha › Alabama › Birmingham
Klinické štúdie Nadváha v meste Birmingham, AL
16 štúdií pre Nadváha hľadá účastníkov v zariadeniach v meste Birmingham a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Prebieha náborFáza 3
- Univ of Alabama Birmingham, Birmingham
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Prebieha náborFáza 2
- University of Alabama - Birmingham, Birmingham
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Prebieha náborFáza 3
- Univ of Alabama Birmingham, Birmingham
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Prebieha náborFáza 3
- Central Research Associates, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Prebieha náborFáza 3
- Birmingham Clinical Research, Birmingham
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Prebieha náborFáza 3
- Birmingham Clinical Research, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Prebieha náborFáza 3
- AURORA-1 Clinical Site, Birmingham
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Prebieha náborFáza 3
- AURORA-2 Clinical Site, Birmingham
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Prebieha náborFáza 3
- Alabama Clinical Therapeutics, Birmingham
- University of Alabama at Birmingham, Birmingham
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Prebieha náborFáza 3Vítaní zdravých dobrovoľníkov
- ACCOMPLISH-2 Research Site, Birmingham
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Prebieha náborFáza 3
- Uni of Alabama at Birmingham, Birmingham
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Prebieha náborFáza 3
- Kailera Clinical Site, Birmingham
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Prebieha náborFáza 3
- ACCOMPLISH-1 Research Site, Birmingham
- ACCOMPLISH-1 Research Site, Birmingham
Time-restricted Eating for Postpartum Weight Loss
Prebieha nábor
- University of Alabama at Birmingham, Birmingham
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Prebieha nábor
- University of Alabama at Birmingham, Birmingham
FELLAShip to Better Health
Prebieha nábor
- The Worship Center Cristian Church, Birmingham
Štúdie Nadváha v iných mestách
- San Antonio, TX34 štúdií
- Houston, TX33 štúdií
- Chicago, IL28 štúdií
- Orlando, FL27 štúdií
- Las Vegas, NV23 štúdií
- Miami, FL23 štúdií
- Atlanta, GA20 štúdií
- Dallas, TX20 štúdií
- New York City, NY19 štúdií
- Jacksonville, FL19 štúdií
- Washington, DC19 štúdií
- Austin, TX18 štúdií
Iné štúdie v Birmingham
- Rakovina (všetky typy)30 štúdií
- Rakovina prsníka24 štúdií
- Obézita23 štúdií
- Rakovina vaječníkov23 štúdií
- Nemalobunkový karcinóm pľúc22 štúdií
- Akútna myeloidná leukémia21 štúdií
- Mnohonásobný myelóm18 štúdií
- CHOPN17 štúdií
- Kardiovaskulárne ochorenia17 štúdií
- Rakovina endometria16 štúdií
- Diabetes mellitus 2. typu16 štúdií
- Cystická fibróza16 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.